- Home
- APVO vs CASK Comparison
APVO vs CASK Comparison
Compare APVO & CASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- CASK
- Stock Information
- Founded
- APVO 2016
- CASK 2011
- Country
- APVO United States
- CASK United States
- Employees
- APVO N/A
- CASK N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- CASK
- Sector
- APVO Health Care
- CASK
- Exchange
- APVO Nasdaq
- CASK NYSE
- Market Cap
- APVO 4.1M
- CASK 4.3M
- IPO Year
- APVO N/A
- CASK 2024
- Fundamental
- Price
- APVO $3.23
- CASK $0.36
- Analyst Decision
- APVO Strong Buy
- CASK
- Analyst Count
- APVO 1
- CASK 0
- Target Price
- APVO $5,920.00
- CASK N/A
- AVG Volume (30 Days)
- APVO 6.7M
- CASK 632.8K
- Earning Date
- APVO 08-07-2025
- CASK 08-25-2025
- Dividend Yield
- APVO N/A
- CASK N/A
- EPS Growth
- APVO N/A
- CASK N/A
- EPS
- APVO N/A
- CASK N/A
- Revenue
- APVO N/A
- CASK $7,571,505.00
- Revenue This Year
- APVO N/A
- CASK N/A
- Revenue Next Year
- APVO N/A
- CASK N/A
- P/E Ratio
- APVO N/A
- CASK N/A
- Revenue Growth
- APVO N/A
- CASK N/A
- 52 Week Low
- APVO $2.81
- CASK $0.27
- 52 Week High
- APVO $485.37
- CASK $4.00
- Technical
- Relative Strength Index (RSI)
- APVO 34.28
- CASK N/A
- Support Level
- APVO $2.81
- CASK N/A
- Resistance Level
- APVO $13.11
- CASK N/A
- Average True Range (ATR)
- APVO 1.10
- CASK 0.00
- MACD
- APVO 0.30
- CASK 0.00
- Stochastic Oscillator
- APVO 4.08
- CASK 0.00
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About CASK HERITAGE DISTILLING HOLDING COMPANY INC
Heritage Distilling Holding Co Inc is a craft distiller producing, marketing, and selling a diverse line of award-winning craft spirits, including whiskeys, vodkas, gins, rums, and ready-to-drink canned cocktails. The company sells its products through wholesale distribution, directly to consumers through its owned and operated distilleries and tasting rooms located in Washington and Oregon, and by shipping directly to consumers online, where legal. Currently, it sells products in the Pacific Northwest with limited distribution in other states throughout the U.S.